Most people recognize Alzheimer’s from its devastating symptoms such as memory loss, while new drugs…
karnottSeptember 5, 2025
Chimeric antigen receptor (CAR) T cell therapy targeting CD19 elicits remarkable clinical efficacy in B…
karnottSeptember 4, 2025
MCB is pleased to announce that MCB Assistant Professor Kazuki Nagashima has received a $100,000…
karnottSeptember 4, 2025
In a landmark first for the continent hardest hit by HIV, a new clinical trial…
karnottSeptember 4, 2025
The Brink’s latest collection of news nuggets, short stories, and other thought-provoking snippets from the…
karnottSeptember 3, 2025
Women with obesity-driven type 2 diabetes (T2D) face worse breast cancer outcomes, yet metabolic status…
karnottSeptember 3, 2025
One of the most captivating mysteries about the immune system is how it manages to…
karnottSeptember 2, 2025
A world-class biomedical research laboratory sits in an unassuming recycled shipping container in a neighborhood…
karnottSeptember 2, 2025
Despite the remarkable fidelity of eukaryotic DNA replication, nucleotide misincorporation errors occur in every replication…
karnottSeptember 1, 2025
